A citation-based method for searching scientific literature

M I Harris, R Klein, T A Welborn, M W Knuiman. Diabetes Care 1992
Times Cited: 913







List of co-cited articles
307 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence.
Massimo Porta, Giulia Curletto, Dario Cipullo, Roberta Rigault de la Longrais, Marina Trento, Pietro Passera, Anna Viola Taulaigo, Sabrina Di Miceli, Antonella Cenci, Paola Dalmasso,[...]. Diabetes Care 2014
62
19

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
11

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
10



10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
7




Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
Sophia Zoungas, Mark Woodward, Qiang Li, Mark E Cooper, Pavel Hamet, Stephen Harrap, Simon Heller, Michel Marre, Anushka Patel, Neil Poulter,[...]. Diabetologia 2014
210
7


Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
6


The diabetes risk score: a practical tool to predict type 2 diabetes risk.
Jaana Lindström, Jaakko Tuomilehto. Diabetes Care 2003
6

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
6

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.
Clare L Gillies, Paul C Lambert, Keith R Abrams, Alex J Sutton, Nicola J Cooper, Ron T Hsu, Melanie J Davies, Kamlesh Khunti. BMJ 2008
193
5

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
5

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5


Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.
Ali Abbasi, Linda M Peelen, Eva Corpeleijn, Yvonne T van der Schouw, Ronald P Stolk, Annemieke M W Spijkerman, Daphne L van der A, Karel G M Moons, Gerjan Navis, Stephan J L Bakker,[...]. BMJ 2012
188
5

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
5


IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.
David R Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw. Diabetes Res Clin Pract 2011
5

Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).
William H Herman, Wen Ye, Simon J Griffin, Rebecca K Simmons, Melanie J Davies, Kamlesh Khunti, Guy E H M Rutten, Annelli Sandbaek, Torsten Lauritzen, Knut Borch-Johnsen,[...]. Diabetes Care 2015
144
5

Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.
Andy Menke, Sarah Casagrande, Linda Geiss, Catherine C Cowie. JAMA 2015
5

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
5

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
5

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
4

Risk models and scores for type 2 diabetes: systematic review.
Douglas Noble, Rohini Mathur, Tom Dent, Catherine Meads, Trisha Greenhalgh. BMJ 2011
344
4

Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.
Rahul Pannala, Jeffery B Leirness, William R Bamlet, Ananda Basu, Gloria M Petersen, Suresh T Chari. Gastroenterology 2008
333
4

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
4

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
4

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
Simon J Griffin, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy E H M Rutten, Annelli Sandbæk, Stephen J Sharp, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham,[...]. Lancet 2011
312
4


The metabolic syndrome--a new worldwide definition.
K George M M Alberti, Paul Zimmet, Jonathan Shaw. Lancet 2005
4

Delay in diagnosis of diabetes is not the patient's fault.
Lisa-Ann Fraser, Jennifer Twombly, Ming Zhu, Qi Long, John J Hanfelt, K M Venkat Narayan, Peter W F Wilson, Lawrence S Phillips. Diabetes Care 2010
11
36

A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes.
W H Herman, P J Smith, T J Thompson, M M Engelgau, R E Aubert. Diabetes Care 1995
153
4


Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study.
Annemieke M W Spijkerman, Jacqueline M Dekker, Giel Nijpels, Marcel C Adriaanse, Piet J Kostense, Dirk Ruwaard, Coen D A Stehouwer, Lex M Bouter, Robert J Heine. Diabetes Care 2003
137
4




Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study.
Abel N Kho, M Geoffrey Hayes, Laura Rasmussen-Torvik, Jennifer A Pacheco, William K Thompson, Loren L Armstrong, Joshua C Denny, Peggy L Peissig, Aaron W Miller, Wei-Qi Wei,[...]. J Am Med Inform Assoc 2012
193
3

Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013.
Kevin M Pantalone, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Michael W Kattan, Jonathan Bouchard, Kevin M Chagin, Changhong Yu, Brian Sakurada, Alex Milinovich,[...]. Clin Med Insights Endocrinol Diabetes 2016
8
37

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
3

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
3

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
3

Changes in diabetes-related complications in the United States, 1990-2010.
Edward W Gregg, Yanfeng Li, Jing Wang, Nilka Rios Burrows, Mohammed K Ali, Deborah Rolka, Desmond E Williams, Linda Geiss. N Engl J Med 2014
997
3

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
Ralph B D'Agostino, Ramachandran S Vasan, Michael J Pencina, Philip A Wolf, Mark Cobain, Joseph M Massaro, William B Kannel. Circulation 2008
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.